Webinars

Webinars

Past Webinars


Webinar Date:
In this seminar, we will discuss the particularly striking results from our recent study of NfL in Huntington's disease and why we think it has real potential to change the course of therapeutic development in HD and other neurogenerative diseases.
June 28, 2017
Webinar Date:
Join our CEO Kevin Hrusovsky, Dr. Jessica Gill (NIH) and Dr. Henrik Zetterberg (University of Gothenburg) as they discuss how Simoa Technology uses ultrasensitive biomarker assays to enable precision health with case studies in neurodegeneration and neurotrauma.
December 2, 2016
Webinar Date:
Hosted by Cambridge Healthtech Institute, this webinar will highlight the use of a Simoa custom assay and the commercial tau assay for different applications in mouse and human studies.
Hosted by Cambridge Healthtech Institute
Webinar Date:
Hosted by Cambridge Healthtech Institute, this webinar will describe how blood biomarkers can be used to detect CNS disorders.
Webinar Date:
Miriam Moscovitch-Lopatin, from MassGeneral Institute for Neurodegenerative Disease presented a longitudinal pre-cell biomarker study she conducted on an ultrasensitive Simoa immunoassay for quantifying BDNF levels in cerebral spinal fluid in early Huntington's disease at the inaugural Powering P
Webinar Date:
Alison Joyce from Pfizer, Inc. presented her research on the development of a sensitive homebrew Simoa assay to detect Leucine-rich repeat Kinase 2 (LRRK2) at the inaugural Powering Precision Health Summit 2016.
Webinar Date:
Jessica Gill, PhD, RN, from the National Institute of Health, presented her research on the role of proteomic biomarkers of brain injuries at the inaugural Powering Precision Health Summit 2016.
Webinar Date:
Danielle Graham, PhD from Biogen presented on accelerating exploratory fluid biomarker assay development in neurodegenerative disease at the inaugural Powering Precision Health Summit 2016.
Webinar Date:
Cheryl Wellington, PhD from the University of British Columbia, presented on the functional modeling of the human cerebrovasculature at the inaugural Powering Precision Health Summit 2016.
Webinar Date:
TBIs are common in military personnel and civilians, placing these individuals at high risk for neurological deficits. The reasons why some individuals are at higher risk for these symptoms and deficits remains largely unknown. This webinar explores the topic further.